ArticleACS omega2026
Automated Baseline Correction Evaluation Score for Raman Spectroscopy.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Emerging Plasmonic Nanomaterials for SERS-Based Disease Diagnostics: Innovations, Clinical Challenges, and AI Integration.Molecules (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Raman spectroscopy is a noninvasive technique providing detailed molecular insights into tissue composition, enabling applications in diagnostics and therapy monitoring. However, Raman signals are inherently weak and prone to superimposed background signals, making baseline correction, a critical step to remove background signals, essential. Typically, experts assess the quality of baseline fitting visually, which is subjective, time-consuming, and impractical with large clinical data sets. To address this, we propose the IS (Integrity Spectrum) Score, a quantitative and automatic metric that evaluates baseline correction quality directly from Raman spectra. The algorithm leverages several spectral properties: it measures the distance between the baseline and the band's prominence, quantifies the Raman shift distances within band edges using a band prominence-proportional factor, compares area-under-the-curve differences between the raw spectrum and an intentionally overfitted baseline, and counts dips where the baseline rises above the spectral curve. These combined indicators capture both underfitting and overfitting behaviors without requiring ground truth labels or manual inspection. Results obtained using complex two-layered blood cell data sets show a strong correlation between IS-Score and expert evaluations, while substantially reducing the time required from experts. This method supports multicenter studies by facilitating consistent baseline correction, reducing labor, and minimizing subjective bias, ultimately enhancing the reliability and comparability of Raman data for clinical research.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.